These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15345810)

  • 21. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Little evidence of reduced survival to adulthood of apoE epsilon4 homozygotes in Down's syndrome.
    Edland SD; Wijsman EM; Schoder-Ehri GL; Leverenz JB
    Neuroreport; 1997 Nov; 8(16):3463-5. PubMed ID: 9427308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total serum cholesterol levels and Alzheimer's dementia in patients with Down syndrome.
    Prasher VP; Airuehia E; Patel A; Haque MS
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):937-42. PubMed ID: 18395888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome.
    Sekijima Y; Ikeda S; Tokuda T; Satoh S; Hidaka H; Hidaka E; Ishikawa M; Yanagisawa N
    Eur Neurol; 1998; 39(4):234-7. PubMed ID: 9635475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 positive individuals demonstrate delayed olfactory event-related potentials.
    Wetter S; Murphy C
    Neurobiol Aging; 2001; 22(3):439-47. PubMed ID: 11378251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults.
    Handley OJ; Morrison CM; Miles C; Bayer AJ
    Neurobiol Aging; 2006 Oct; 27(10):1425-30. PubMed ID: 16202482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
    Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.
    Bennett DA; Wilson RS; Schneider JA; Evans DA; Aggarwal NT; Arnold SE; Cochran EJ; Berry-Kravis E; Bienias JL
    Neurology; 2003 Jan; 60(2):246-52. PubMed ID: 12552039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.
    Tsuang D; Larson EB; Bowen J; McCormick W; Teri L; Nochlin D; Leverenz JB; Peskind ER; Lim A; Raskind MA; Thompson ML; Mirra SS; Gearing M; Schellenberg GD; Kukull W
    Arch Neurol; 1999 Dec; 56(12):1489-95. PubMed ID: 10593304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of risk factors of Alzheimer's disease in the Down syndrome.
    Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction.
    Bacon AW; Bondi MW; Salmon DP; Murphy C
    Ann N Y Acad Sci; 1998 Nov; 855():723-31. PubMed ID: 9929677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia.
    Olofsson JK; Nordin S; Wiens S; Hedner M; Nilsson LG; Larsson M
    Neurobiol Aging; 2010 Apr; 31(4):567-77. PubMed ID: 18619712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
    Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
    J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease.
    Welsh-Bohmer KA; Gearing M; Saunders AM; Roses AD; Mirra S
    Ann Neurol; 1997 Sep; 42(3):319-25. PubMed ID: 9307253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment.
    Wang QS; Tian L; Huang YL; Qin S; He LQ; Zhou JN
    Brain Res; 2002 Sep; 951(1):77-81. PubMed ID: 12231459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.